don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"The Uromigos","authorlink":""},"src":"https:\/\/anchor.fm\/s\/13347ea8\/podcast\/play\/57366338\/https:\/\/d3ctxlq1ktw2nl.cloudfront.net\/staging\/2022-8-10\/c94c055d-0dea-5d3d-2f4b-16e89fb6717b.mp3","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202311\/9a74be-6c97-2fc6-cfefc2_800.jpg"},"title":"Episode 191 ESMO 2022: PROSPER study of neoadjuvant nivolumab in RCC","link":"javascript:;","id":"item-33468857"}]
